Research output per year
Research output per year
Research activity per year
Dr. Yadollah Omidi joined Nova Southeastern University College of Pharmacy in August 2020 to work as a full professor of pharmaceutical sciences.
Dr. Omidi obtained his Ph.D. degree in the field of brain drug delivery and targeting from Cardiff University, United Kingdom, in 2003 and his Pharm.D. degree from Tabriz University of Medical Sciences (TUOMS), Iran, in 1991. He has completed a postdoctoral research associate program, studying gene-based nanomedicines and toxicogenomics at Cardiff University School of Pharmacy. As a professor of drug delivery and targeting, Dr. Omidi has several years of experience in teaching different subjects of pharmaceutical sciences and supervising Pharm.D., M.Sc., Ph.D., and M.D. students. He acted as the founding director of the TUOMS Research Center for Pharmaceutical Nanotechnology. He is the founding Editor-in-Chief of Bioimpacts, and also serves on the editorial board of several international journals, including Nanomedicine, Biologicals, DARU Journal of Pharmaceutical Sciences, and BMC Pharmacology and Toxicology. Dr. Omidi is a collaborator of several scientists from the U.S., and Europe. In 2011, he joined the Ovarian Cancer Research Center at the University of Pennsylvania (United States) as a visiting associate professor to undertake translational research towards the development of multifunctional nanomedicines and theranostics for targeted therapy of ovarian cancer with a particular focus on drug targeting of the tumor microenvironment.
Dr. Omidi's research interests are focused on different areas of pharmaceutical sciences, including drug delivery and targeting, multifunctional nanomedicines and theranostics, biological membranes and barriers, vaccines and immunotherapeutics, nanobiomaterials for cell/tissue engineering, and diagnostic nanobiosystems. Since 2003, Dr. Omidi has published over 330 papers in peer-reviewed international journals. He is also the author of 30 book chapters and the recipient of several teaching and research awards. Listed among the top 1% of scientists worldwide by the ESI-WoS, he has an h-index of 65 and an i10-index of 251 with over 14550 citations.
PHRP-8250: Advanced Topics in Pharmaceutical Sciences
PHRE-5210: Modern Medicine
PHRC-4850: Pharmaceutical Calculations
Ph.D., Pharmaceutical Sciences, Cardiff University - United Kingdom
1999 → 2003
Pharm.D., Tabriz University of Medical Sciences
1986 → 1991
Founding Head, Tabriz University of Medical Sciences Biomedicine Institute
2017 → 2018
Founding Director, HopePharmTech
2016 → …
Full Professor, Tabriz University of Medical Sciences
2014 → 2019
Founding Head, National Institute of Medical Research
2013 → 2017
Associate Professor, Tabriz University of Medical Sciences
2013 → 2014
Founding Editor-in-Chief, Bioimpacts
2011 → …
Visiting Associate Professor, University of Pennsylvania
2011 → 2013
Advisory Board Member, Tabriz University of Medical Sciences
2010 → 2013
Associate Professor, Tabriz University of Medical Sciences
2008 → 2011
Founding Dean, Tabriz University of Medical Sciences School of Advanced Biomedical Sciences
2008 → 2010
Principal Investigator, Tabriz University of Medical Sciences
2005 → 2018
Assistant Professor, Tabriz University of Medical Sciences
2004 → 2008
Postdoctoral Research Associate, Cardiff University - United Kingdom
2003 → 2004
Lecturer, Tabriz University of Medical Sciences
1991 → 1998
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
10/13/25
1 item of Media coverage
Press/Media: Research